CORRECTION article

Front. Pharmacol., 30 July 2025

Sec. Gastrointestinal and Hepatic Pharmacology

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1662597

Correction: Understanding the role of the gut microbiome in gastrointestinal cancer: A review

  • 1. Department of Nutrition and Dietetics, Gazi University, Emek, Ankara, Türkiye

  • 2. MERCK S.P.A., Rome, Italy

  • 3. Department of Pharmacy, University of Naples “Federico II”, Naples, Italy

  • 4. Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, Italy

  • 5. Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

  • 6. Department of Histology and Embryology, Kütahya Health Sciences University, Kütahya, Türkiye

  • 7. Department of Translational Medical Science and ImmunoNutritionLab at CEINGE Biotechnologies Research Center and Task Force for Microbiome Studies, University of Naples Federico II, Naples, Italy

  • 8. Department of Agricultural Sciences, University of Naples Federico II, Portici, Italy

Article metrics

View details

1,1k

Views

286

Downloads

In the published article, an incorrect Funding statement was provided. The corrected Funding statement appears below.

The original article has been updated.

Statements

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. The paper was funded under the National Recovery and Resilience Plan (NRRP), Mission 4 Component 2 Investment 1.3—Call for tender No. 341 of 15 March 2022 of Italian Ministry of University and Research funded by the European Union—NextGenerationEU. Project code PE00000003, Concession Decree No. 1550 of 11 October 2022, adopted by the Italian Ministry of University and Research, CUP E63C22002030007, Project title “ON Foods—Research and innovation network on food and nutrition Sustainability, Safety and Security—Working ON Foods.”

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

microbiome, gastrointestinal cancer, non-coding RNAs, therapeutics, diagnosis

Citation

Agagündüz D, Cocozza E, Cemali Ö, Bayazıt AD, Nanì MF, Cerqua I, Morgillo F, Saygılı SK, Canani RB, Amero P and Capasso R (2025) Correction: Understanding the role of the gut microbiome in gastrointestinal cancer: A review. Front. Pharmacol. 16:1662597. doi: 10.3389/fphar.2025.1662597

Received

09 July 2025

Accepted

17 July 2025

Published

30 July 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

16 - 2025

Updates

Copyright

*Correspondence: Raffaele Capasso, ; Paola Amero,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics